4//SEC Filing
WALKER WAYNE REMELL 4
Accession 0001683168-25-009115
CIK 0001157075other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:07 PM ET
Size
9.0 KB
Accession
0001683168-25-009115
Insider Transaction Report
Form 4
WALKER WAYNE REMELL
Director
Transactions
- Award
Common Stock
2025-12-12+37,500→ 37,500 total - Tax Payment
Common Stock
2025-12-12$1.02/sh−16,875$17,213→ 20,625 total - Award
Stock Option (Right to Buy)
2025-04-25+63,233→ 63,233 totalExercise: $1.22Exp: 2035-04-24→ Common Stock (63,233 underlying)
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
- [F2]The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Walker. This transaction is late due to an inadvertent administrative error and not any error of Mr. Walker.
Documents
Issuer
PharmaCyte Biotech, Inc.
CIK 0001157075
Entity typeother
Related Parties
1- filerCIK 0001428761
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:07 PM ET
- Size
- 9.0 KB